The author of a now-retracted study linking autism to childhood vaccines expected a related medical test to rack up sales of up to $43 million a year, a British medical journal reported Tuesday.Git a rope ...
The report in the medical journal BMJ is the second in a series sharply critical of Dr. Andrew Wakefield, who reported the link in 1998. It follows the journal's declaration last week that the 1998 paper in which Wakefield first suggested a connection between autism and the measles, mumps and rubella, or MMR, vaccine was an "elaborate fraud."
Find a tree ...
The venture "was to be launched off the back of the vaccine scare, diagnosing a purported -- and still unsubstantiated -- 'new syndrome,'" BMJ reported Tuesday. A prospectus for potential investors suggested that a test for the disorder Wakefield dubbed "autistic enterocolitis" could produce as much as 28 million pounds ($43 million U.S.) in revenue, the journal reported, with "litigation driven testing" of patients in the United States and Britain its initial market.
Insert perp ...
Among his partners in the enterprise was the father of one of the 12 children in the 1998 study that launched the controversy, the journal reported.
Oh, did I put up the noose picture? Sorry about that. Hopefully everyone here will take it the right way.
Rhetorically speaking, of course...